PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 79 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $746,000 | -35.4% | 547,800 | -10.8% | 0.02% | -31.0% |
Q2 2014 | $1,155,000 | -9.6% | 614,300 | -8.6% | 0.03% | +11.5% |
Q1 2014 | $1,277,000 | +36.7% | 671,900 | 0.0% | 0.03% | +30.0% |
Q4 2013 | $934,000 | -1.6% | 671,900 | -0.8% | 0.02% | -4.8% |
Q3 2013 | $949,000 | +8.6% | 677,500 | 0.0% | 0.02% | +23.5% |
Q2 2013 | $874,000 | – | 677,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |